6EVK image
Deposition Date 2017-11-01
Release Date 2017-12-13
Last Version Date 2024-01-17
Entry Detail
PDB ID:
6EVK
Keywords:
Title:
Crystal structure of bat influenza A/H17N10 polymerase with viral RNA promoter and cap analogue m7GTP
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.90 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Polymerase acidic protein
Gene (Uniprot):PA
Chain IDs:A
Chain Length:738
Number of Molecules:1
Biological Source:Influenza A virus (A/little yellow-shouldered bat/Guatemala/060/2010(H17N10))
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase catalytic subunit
Gene (Uniprot):PB1
Chain IDs:B
Chain Length:776
Number of Molecules:1
Biological Source:Influenza A virus (A/little yellow-shouldered bat/Guatemala/060/2010(H17N10))
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Polymerase basic protein 2
Gene (Uniprot):PB2
Chain IDs:C
Chain Length:809
Number of Molecules:1
Biological Source:Influenza A virus (A/little yellow-shouldered bat/Guatemala/060/2010(H17N10))
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(*UP*AP*UP*AP*CP*CP*UP*CP*UP*GP*CP*UP*U)-3')
Chain IDs:D (auth: R)
Chain Length:18
Number of Molecules:1
Biological Source:Influenza A virus
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*AP*GP*UP*AP*GP*UP*AP*AP*CP*AP*AP*GP*AP*GP*GP*G)-3')
Chain IDs:E (auth: V)
Chain Length:16
Number of Molecules:1
Biological Source:Influenza A virus
Primary Citation
Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors.
Nucleic Acids Res. 46 956 971 (2018)
PMID: 29202182 DOI: 10.1093/nar/gkx1210

Abstact

Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation ('priming state') and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the 'apo' state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the 'apo' state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive 'apo' state.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback